Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katrine Finderup Nielsen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Ugeskrift for Laeger|March 4, 2022
[COVID-19 among children and adolescents]Astrid Blicher Schelde, Katrine Finderup Nielsen, Ulrikka Nygaard, et al.
Plos Medicine|December 17, 2021
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort studyMie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 25, 2022
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort studyKatrine Finderup Nielsen, Lise Birk Nielsen, Frederikke Kristensen Lomholt, et al.
Emerging Infectious Diseases|May 23, 2024
Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, DenmarkKatrine Finderup Nielsen, Lise Birk Nielsen, Tine Dalby, et al.
Plos Medicine|November 22, 2022
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide studyKatrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 29, 2022
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022Alexis Sentís, Irina Kislaya, Nathalie Nicolay, et al.
Influenza and Other Respiratory Viruses|November 29, 2023
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022Irina Kislaya, Alexis Sentís, Jostein Starrfelt, et al.
Plos Medicine|September 1, 2022
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort studyMie Agermose Gram, Hanne-Dorthe Emborg, Astrid Blicher Schelde, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Ugeskrift for Laeger|March 4, 2022
[COVID-19 among children and adolescents]Astrid Blicher Schelde, Katrine Finderup Nielsen, Ulrikka Nygaard, et al.
Plos Medicine|December 17, 2021
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort studyMie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|October 25, 2022
Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort studyKatrine Finderup Nielsen, Lise Birk Nielsen, Frederikke Kristensen Lomholt, et al.
Emerging Infectious Diseases|May 23, 2024
Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, DenmarkKatrine Finderup Nielsen, Lise Birk Nielsen, Tine Dalby, et al.
Plos Medicine|November 22, 2022
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide studyKatrine Finderup Nielsen, Ida Rask Moustsen-Helms, Astrid Blicher Schelde, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|July 29, 2022
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022Alexis Sentís, Irina Kislaya, Nathalie Nicolay, et al.
Influenza and Other Respiratory Viruses|November 29, 2023
Monitoring COVID-19 vaccine effectiveness against COVID-19 hospitalisation and death using electronic health registries in ≥65 years old population in six European countries, October 2021 to November 2022Irina Kislaya, Alexis Sentís, Jostein Starrfelt, et al.
Plos Medicine|September 1, 2022
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort studyMie Agermose Gram, Hanne-Dorthe Emborg, Astrid Blicher Schelde, et al.
Pageof 1